Agreed with the success of trials and the consequent valuation and FOMO that will occur. BOT have done a great job but don't forget we also have ability to distribute products within the Australian Market (licence and Cannvalate connection), we have a dental side of the business that has some relevance to the trials we will conduct, we have agreements for products and their supply, we have 4 upcoming trials (hence 4 cracks at success) and we still have this MC! Oh yeah don't forget we keep the IP for the trials too. Am I saying we should be 250M MC at the moment...no, however the directors have created a well rounded business here with multiple chances of creating huge value.
As for the oppies they are just in low supply and I can tell you that they are pretty tightly held. Certainly mine are anyway.
Anyway we are all on the same side and there is good sentiment in the sector and we are all well poised for good returns IMO.
IHL Price at posting:
4.6¢ Sentiment: Buy Disclosure: Held
